Matthew McCarley, a partner at Fears | Nachawati Law Firm, has been appointed to the Plaintiffs’ Executive Committee (PEC) in the multidistrict litigation (MDL) regarding Inferior Vena Cava (IVC) Filters manufactured by Cook Group, Inc.   IVC Filters were implanted to prevent blood clots from becoming coronary or pulmonary embolisms. However, reports first surfaced in

Xarelto, the blockbuster anticoagulant that was approved by the FDA in 2011, has continued to come under scrutiny by parts of the medical community. Initially, the drug was approved to help reduce the risk of blood clots in patients who had undergone knee or hip replacement. Later, Xarelto was approved to help patients with deep

More recently, a significant number of women and theirs families have brought lawsuits against various manufacturers after doctors used laparoscopic power morcellators during their hysterectomies. These individuals allege that these devices were responsible for spreading undiagnosed cancers and that they were not adequately warned about the potentially deadly risk.

Laparoscopic power morcellators have been used

Pictured above: The totaled car after the unfortunate accident 

The holidays are always a dangerous time to be on the road and this Fourth of July weekend was no different. An unfortunate accident involving a drunk driver and his passenger occurred early on Saturday, July 4th in Milwaukee, Wisconsin. The accident happened near the intersection

Another transvaginal mesh manufacturer has agreed to settle with injured plaintiffs. This time, the company is Covidien, which has agree to settle some of the 11,000 claims that are currently being made against them. Covidien has supplied C.R. Bard with mesh products, specifically Bard’s Avaulta pelvic mesh. In 2013, Bard was ordered to pay Donna

We are proud to announce that Fears | Nachawati Law Firm Partner, Majed Nachawati, has recently been appointed as Panel Chairman on Panel 2, District 6 Grievance Committee of the State Bar of Texas. This appointment is highly prestigious, as the position is filled based up on nominations from other grievance committee members, and ultimately